Other mechanisms of action include enzymatic degradation of the extracellular matrix and tumor cell attachments, alteration of signaling through modification of the surface ligands and receptors (such as Notch, HER2, EGFR, and NKG2D). This evidence concerns the gene ERBB2 and neoplasm.